Summary
Boston Scientific Corporation (BSX) filed an 8-K on July 25, 2018, to report its financial results for the second quarter ended June 30, 2018. The report primarily references a press release issued on the same day, which contains the detailed financial performance and operational updates for the period. Investors should refer to the furnished press release (Exhibit 99.1) for specific figures on revenue, earnings, and segment performance, as well as management's commentary on the company's strategic direction and outlook.
Key Highlights
- 1Boston Scientific announced its second quarter 2018 financial results on July 25, 2018.
- 2The 8-K filing includes a press release as Exhibit 99.1, containing the full details of the Q2 2018 financial performance.
- 3Investors are directed to the press release for specific financial data and operational commentary.
- 4The filing does not contain new financial statements but rather references a separately issued press release.
- 5This report serves as the official notification mechanism for the company's quarterly earnings announcement.
- 6Information furnished in Item 2.02 is not considered 'filed' for certain SEC purposes, limiting specific liabilities under Section 18 of the Exchange Act.